163 related articles for article (PubMed ID: 9529128)
1. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
Beguin Y; Clemons GK; Pootrakul P; Fillet G
Blood; 1993 Feb; 81(4):1067-76. PubMed ID: 8427988
[TBL] [Abstract][Full Text] [Related]
3. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
[TBL] [Abstract][Full Text] [Related]
4. Erythroid marrow function in anemic patients.
Cazzola M; Pootrakul P; Huebers HA; Eng M; Eschbach J; Finch CA
Blood; 1987 Jan; 69(1):296-301. PubMed ID: 3098323
[TBL] [Abstract][Full Text] [Related]
5. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
6. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
Brada SJ; de Wolf JT; Hendriks DW; Smit JW; Vellenga E
Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
[TBL] [Abstract][Full Text] [Related]
7. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors.
R'zik S; Beguin Y
Exp Hematol; 2001 Jun; 29(6):677-85. PubMed ID: 11378262
[TBL] [Abstract][Full Text] [Related]
9. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
[TBL] [Abstract][Full Text] [Related]
10. Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors.
Suzuki H; Asano H; Ohashi H; Kinoshita T; Murate T; Saito H; Hotta T
Leukemia; 1999 Jan; 13(1):130-4. PubMed ID: 10049048
[TBL] [Abstract][Full Text] [Related]
11. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
12. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
13. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
14. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221
[TBL] [Abstract][Full Text] [Related]
15. Colony formation by megakaryocyte progenitors in myelodysplatic syndromes.
Juvonen E; Partanen S; Knuutila S; Ruutu T
Eur J Haematol; 1989 Apr; 42(4):389-95. PubMed ID: 2721661
[TBL] [Abstract][Full Text] [Related]
16. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion.
Tancabelic J; Sheth S; Paik M; Piomelli S
Am J Hematol; 1999 Feb; 60(2):121-5. PubMed ID: 9929103
[TBL] [Abstract][Full Text] [Related]
17. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
Backx B; Broeders L; Löwenberg B
Blood; 1992 Sep; 80(5):1213-7. PubMed ID: 1381239
[TBL] [Abstract][Full Text] [Related]
18. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological classification of acquired bone marrow failure based on quantitative assessment of erythroid function.
Cazzola M; Bergamaschi G; Huebers HA; Finch CA
Eur J Haematol; 1987 May; 38(5):426-32. PubMed ID: 3653364
[TBL] [Abstract][Full Text] [Related]
20. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]